Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. Our company/
  3. Social impact /
  4. Global health equity /
  5. Treating Children At Risk for Intestinal Worms

Treating children at risk for intestinal worms

Intestinal worms infections rob children of vital nutrients and a bright future. By donating deworming medication and supporting hygiene education programs, we are working toward a world where children learn and play, free of intestinal worms.

More from Johnson & Johnson

What you need to know about Johnson & Johnson’s 2025 third-quarter earnings

Here’s an infographic breakdown of the company’s third-quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses.

How Johnson & Johnson is helping healthcare providers remotely monitor and support patient health

Expertise, innovation and insight are fueling the development of remote and AI-powered approaches to healthcare—potentially improving treatment decisions and evolving the way clinical trials are designed and managed.

“Patients are the center of everything": Meet the scientist leader dedicated to developing effective IBD treatments

Her natural curiosity, determination and fascination with science inspired Esi Lamousé, M.D., Ph.D., to pursue a career that’s helped bring innovative therapies for inflammatory bowel disease to patients in need around the world.